TrialRetrovirology2016

HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.

Barbara Ensoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.